Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232-Reference-Cited by-同舟云学术

Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232

Published:2017-12-23 Issue:1 Volume:7 Page:3-12
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

DiNofia Amanda M.¹²^ORCID,Seif Alix E.¹²,Devidas Meenakshi³,Li Yimei¹⁴,Hall Matthew⁵,Huang Yuan-Shung V.⁶,Cahen Viviane¹,Hunger Stephen P.¹²,Winick Naomi J.⁷,Carroll William L.⁸,Fisher Brian T.²⁴⁶⁹,Larsen Eric C.¹⁰,Aplenc Richard¹²⁴⁶

Affiliation:

1. Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania

2. Department of Pediatrics; University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania

3. Division of Biostatistics; University of Florida; Gainesville Florida

4. The Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania

5. Children's Hospital Association; Lenexa Kansas

6. Center for Pediatric Clinical Effectiveness; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania

7. Division of Hematology-Oncology; Department of Pediatrics; Center for Cancer and Blood Disorders; University of Texas at Southwestern Medical Center; Dallas Texas

8. Perlmutter Cancer Center Departments of Pediatrics and Pathology; NYU Langone Medical Center; New York New York

9. Division of Infectious Diseases; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania

10. Division of Pediatric Hematology/Oncology; Maine Medical Center; Scarborough Maine

Funder

National Institutes of Health

Alex's Lemonade Stand Foundation for Childhood Cancer

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. The value equation: enhancing patient outcomes while constraining costs;Scheurer;Am. J. Med. Sci.,2016